Traditional West European
and North American Pharmaceutical Ingredient Manufacturers have been
Replaced by Indian Pharmaceutical Ingredient Manufacturers and Chinese Pharmaceutical
Manufacturers Creating Potential for Dangerous Adulterated Drugs and Pharmaceutical Supply Chain Fraud by
International Pharmaceutical Supply Chain Fraud
Whistleblower Reward Lawyer, International Adulterated Active Pharmaceutical Ingredient
Whistleblower Lawyer, and International Pharmaceutical
Excipient Whistleblower Reward Lawyer Jason S. Coomer
The pharmaceutical ingredient market including pharmaceutical excipient manufacturers, pharmaceutical intermediate manufacturers, and active pharmaceutical
ingredient (API) manufacturers has become very competitive with
many international pharmaceutical ingredient producers. As large pharmaceutical companies and the pharmaceutical industry compete to lower the cost of drug production, the drug companies are seeking the cheapest pharmaceutical ingredients that they can locate. As such, many of the drug companies driven
by profits and lower costs are moving their API manufacturing, pharmaceutical excipient suppliers, and pharmaceutical intermediate suppliers from Western countries to India and China.
Unfortunately, in some situations the pharmaceutical ingredient manufacturer is not properly regulated and the drug ingredients are contaminated, not produced under good manufacturing practices, contain dangerous foreign substances, or are otherwise adulterated.
International Whistleblowers that are aware of these adulterated pharmaceutical ingredients
are needed to blow the whistle on quality assurance fraud, adulterated drugs, and pharmaceutical supply chain fraud. As such, whistleblower reward laws are in place that offer large potential rewards and whistleblower protections to whistleblowers that blow the whistle on adulterated
pharmaceutical ingredients, adulterated medicine,
adulterated drugs, contaminated medical supplies,
and defective medical
devices.
Traditional West European
and North American API Manufacturers have been
Replaced by Indian API Manufacturers and Chinese API Manufacturers
The overall API market was valued
at $101.08 billion in 2010, and is expected to grow
at a CAGR of 7.9% from 2011 to 2016. The market share held by Indian
API manufacturers in the global API merchant market
(generic APIs and branded/innovator APIs) was 6.5%
in 2005, 12.0% in 2010, and is expected to increase
to 22.0% by 2015. India’s share of the global
generic API merchant market has increased from 13.5%
in 2005 to 22.1% in 2010 and is expected to increase
to 33.3% by 2015. Export sales of generic APIs from
India increased at an average of 18.9% between
2005–2010 compared with an annual average of 15.9%
to the country’s domestic market. India is
expected to be the fastest growing API supplier
during the next five years and will keep its
position above China.
The market share held by Chinese
companies in the global API merchant market (generic
APIs and branded/innovative APIs) has risen from
14.2% in 2005 to 19% in 2010. The market share held
by Chinese companies in the global generic API
merchant market increased from 31.1% in 2005 to
35.6% in 2010. Although China remains the largest
API supplier on a global basis, growth rates from
2005–2010 of Chinese API suppliers were less than
those of Indian suppliers.
Traditional West European
and North American Excipient Manufacturers have been
Replaced by Indian Excipient Manufacturers and Chinese
Excipient Manufacturers
Pharmaceutical
excipients play an important role in pharmaceutical
formulations by adding functionality or by
facilitating the processing of a drug product.
Recent trends in the pharmaceutical excipient
manufacturer industry include: geographic expansion
and select investment in emerging markets. In other word excipient manufacturing like API manufacturing and pharmaceutical intermediate manufacturing are moving from western countries to India and China.
The global market for excipients
totaled $4.9 billion in 2011. That value is
projected to reach more than $6.7 billion in 2016
after increasing at a five-year compound annual
growth rate (CAGR) of 6.5%. The global
excipients market can be broken down by material
type into three segments – organic, inorganic, and
USP (U.S. pharmaceutical) water.
International Adulterated
Drug Supply
Chain Whistleblower Reward Lawyer, International
Pharmaceutical Supply Chain Fraud Whistleblower
Lawyer, Medical Device Supply Chain Illegal Kickback Lawyer,
Medicine Supply Chain Whistleblower Reward Lawyer, Medicine
Supply Chain Fraud Lawyer, and Pharmaceutical Supply Chain
Foreign Corrupt Practices Act Lawyer
International Whistleblowers along the
pharmaceutical supply chain and other health care
professionals
are being offered large potential rewards to blow the whistle on adulterated
pharmaceutical ingredients, adulterated medicine,
adulterated drugs, contaminated medical supplies,
and defective medical
devices. For more information on International Adulterated
Drug Supply
Chain Whistleblower Reward Lawsuits, please feel free to go to the following web page: International Adulterated Drug Supply Chain Whistleblower Reward Lawsuit Information.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.